<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Eleven patients with primary thunderclap <z:hpo ids='HP_0002315'>headache</z:hpo> (TCH) were treated with oral nimodipine 30 to 60 mg every 4 hours or IV nimodipine 0.5 to 2 mg/h if the oral regimen failed or images showed <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>With oral nimodipine, <z:hpo ids='HP_0002315'>headache</z:hpo> did not recur in the nine patients without vasospasm </plain></SENT>
<SENT sid="2" pm="."><plain>IV nimodipine was given in two patients with vasospasm, including one who developed <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Nimodipine may be effective for TCH </plain></SENT>
<SENT sid="4" pm="."><plain>Vasospasm may warrant IV nimodipine </plain></SENT>
</text></document>